An NCI-designated Comprehensive Cancer Center

Acute Myeloid Leukemia

“We feel blessed that we’re in a good place where we feel that everything’s going to be OK.”
Myrella Rico, cancer survivor and acute myeloid leukemia caregiver

Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal blood cells or platelets. If you have been recently diagnosed with acute myeloid leukemia (AML), talk to the integrated group of specialists at City of Hope’s Gehr Family Center for Leukemia Research.

Request a consultation

If you have been diagnosed with acute myeloid leukemia or are looking for a second opinion consultation about your treatment, you may request an appointment online or contact us at 800-826-4673 (HOPE). Please visit Making Your First Appointment for more information. 

Our Expertise

Located in Southern California, City of Hope has been named a best hospital for cancer by U.S. News & World Report for over a decade, and a National Cancer Institute comprehensive cancer center, the highest designation that recognizes our commitment to cancer treatment, research and education. As a founding member of the National Comprehensive Cancer Network, our doctors also help develop and improve evidence-based AML treatment guidelines for patients throughout the country.

Highlights of our AML program include:

  • Comprehensive genetic and molecular profiling of each patient's cancer, so we can identify treatments that will produce the best outcomes
  • A multidisciplinary team of specialists – including hematologists, medical and radiation oncologists, supportive care experts and other professionals – who work together to provide coordinated, personalized care for you and your loved ones
  • A world-class bone marrow and stem cell transplant program with better-than-expected survival outcomes for over 10 years
  • Leading-edge clinical trials for AML not available elsewhere, including T cell immunotherapy, mutation-specific AML drugs and novel stem cell transplant regimens
  • Total marrow irradiation that targets radiation therapy to bone marrow, where AML originates, while minimizing exposure to healthy tissues and organs
  • Long-term, follow up program to minimize risk of recurrence and improve quality of life for AML survivors


News & Breakthroughs


Help us turn innovative ideas into powerful new treatments
$ Other